Lista de obras -

A versatile T cell-based assay to assess therapeutic antigen-specific PD-1-targeted approaches.

artículo científico publicado en 2018

Abundant expression of TIM-3, LAG-3, PD-1 and PD-L1 as immunotherapy checkpoint targets in effusions of mesothelioma patients

artículo científico publicado en 2017

Acute myeloid leukemic cell lines loaded with synthetic dsRNA trigger IFN-gamma secretion by human NK cells.

artículo científico publicado en 2008

Characterization of Interleukin-15-Transpresenting Dendritic Cells for Clinical Use.

artículo científico publicado en 2017

Clinical use of dendritic cells for cancer therapy.

artículo científico publicado en 2014

Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer Cells

scientific article published on 19 October 2019

Correction: Interleukin-15-Induced CD56 Myeloid Dendritic Cells Combine Potent Tumor Antigen Presentation with Direct Tumoricidal Potential

Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia

artículo científico publicado en 2019

Dendritic Cell-Based and Other Vaccination Strategies for Pediatric Cancer

artículo científico publicado en 2019

Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer.

artículo científico publicado en 2018

Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy.

artículo científico

Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia

artículo científico publicado en 2017

Dendritic cell vaccine therapy for acute myeloid leukemia: questions and answers

artículo científico publicado en 2011

Desirable cytolytic immune effector cell recruitment by interleukin-15 dendritic cells.

artículo científico publicado en 2017

Efficient and Non-genotoxic RNA-Based Engineering of Human T Cells Using Tumor-Specific T Cell Receptors With Minimal TCR Mispairing

artículo científico publicado en 2018

Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapy

artículo científico publicado en 2015

Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions.

artículo científico publicado en 2015

Evaluating a Single Domain Antibody Targeting Human PD-L1 as a Nuclear Imaging and Therapeutic Agent

scientific article published on 21 June 2019

Generation and Cryopreservation of Clinical Grade Wilms' Tumor 1 mRNA-Loaded Dendritic Cell Vaccines for Cancer Immunotherapy.

artículo científico publicado en 2016

HPV vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against HPV-positive tumour cells

artículo científico publicado en 2014

Human tears reveal insights into corneal neovascularization

artículo científico publicado en 2012

IL-15 receptor alpha as the magic wand to boost the success of IL-15 antitumor therapies: The upswing of IL-15 transpresentation.

artículo científico publicado en 2016

Identification of a Wilms' tumor 1-derived immunogenic CD4(+) T-cell epitope that is recognized in the context of common Caucasian HLA-DR haplotypes.

artículo científico publicado en 2012

Increased herpes zoster risk associated with poor HLA-A immediate early 62 protein (IE62) affinity.

artículo científico publicado en 2017

Interferon-α in acute myeloid leukemia: an old drug revisited ⬇️

artículo científico publicado el 28 de enero de 2011

Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner

artículo científico publicado en 2015

Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells

artículo científico publicado en 2016

Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential

artículo científico publicado en 2012

Loading of acute myeloid leukemia cells with poly(I:C) by electroporation.

artículo científico publicado en 2014

Monocyte-Derived Dendritic Cells with Silenced PD-1 Ligands and Transpresenting Interleukin-15 Stimulate Strong Tumor-Reactive T-cell Expansion

artículo científico publicado en 2017

NK cells: key to success of DC-based cancer vaccines?

artículo científico

Natural killer cell immune escape in acute myeloid leukemia.

artículo científico publicado en 2012

PD-L1 siRNA-mediated silencing in acute myeloid leukemia enhances anti-leukemic T cell reactivity

artículo científico publicado en 2020

Poly(I:C) as cancer vaccine adjuvant: knocking on the door of medical breakthroughs.

artículo científico

Poly(I:C) enhances the susceptibility of leukemic cells to NK cell cytotoxicity and phagocytosis by DC

artículo científico publicado en 2011

Quantification of IFN-gamma produced by human purified NK cells following tumor cell stimulation: comparison of three IFN-gamma assays.

artículo científico publicado en 2009

Single Domain Antibody-Mediated Blockade of Programmed Death-Ligand 1 on Dendritic Cells Enhances CD8 T-cell Activation and Cytokine Production

artículo científico publicado en 2019

The Quest for the Best: How TCR Affinity, Avidity, and Functional Avidity Affect TCR-Engineered T-Cell Antitumor Responses

scientific article published on 18 July 2020

Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.

artículo científico publicado en 2015

Lista de obras de

A versatile T cell-based assay to assess therapeutic antigen-specific PD-1-targeted approaches.

Abundant expression of TIM-3, LAG-3, PD-1 and PD-L1 as immunotherapy checkpoint targets in effusions of mesothelioma patients

Acute myeloid leukemic cell lines loaded with synthetic dsRNA trigger IFN-gamma secretion by human NK cells.

Characterization of Interleukin-15-Transpresenting Dendritic Cells for Clinical Use.

Clinical use of dendritic cells for cancer therapy.

Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer Cells

Correction: Interleukin-15-Induced CD56 Myeloid Dendritic Cells Combine Potent Tumor Antigen Presentation with Direct Tumoricidal Potential

Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia

Dendritic Cell-Based and Other Vaccination Strategies for Pediatric Cancer

Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer.

Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy.

Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia

Dendritic cell vaccine therapy for acute myeloid leukemia: questions and answers

Desirable cytolytic immune effector cell recruitment by interleukin-15 dendritic cells.

Efficient and Non-genotoxic RNA-Based Engineering of Human T Cells Using Tumor-Specific T Cell Receptors With Minimal TCR Mispairing

Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapy

Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions.

Evaluating a Single Domain Antibody Targeting Human PD-L1 as a Nuclear Imaging and Therapeutic Agent

Generation and Cryopreservation of Clinical Grade Wilms' Tumor 1 mRNA-Loaded Dendritic Cell Vaccines for Cancer Immunotherapy.

HPV vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against HPV-positive tumour cells

Human tears reveal insights into corneal neovascularization

IL-15 receptor alpha as the magic wand to boost the success of IL-15 antitumor therapies: The upswing of IL-15 transpresentation.

Identification of a Wilms' tumor 1-derived immunogenic CD4(+) T-cell epitope that is recognized in the context of common Caucasian HLA-DR haplotypes.

Increased herpes zoster risk associated with poor HLA-A immediate early 62 protein (IE62) affinity.

Interferon-α in acute myeloid leukemia: an old drug revisited ⬇️

Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner

Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells

Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential

Loading of acute myeloid leukemia cells with poly(I:C) by electroporation.

Monocyte-Derived Dendritic Cells with Silenced PD-1 Ligands and Transpresenting Interleukin-15 Stimulate Strong Tumor-Reactive T-cell Expansion

NK cells: key to success of DC-based cancer vaccines?

Natural killer cell immune escape in acute myeloid leukemia.

PD-L1 siRNA-mediated silencing in acute myeloid leukemia enhances anti-leukemic T cell reactivity

Poly(I:C) as cancer vaccine adjuvant: knocking on the door of medical breakthroughs.

Poly(I:C) enhances the susceptibility of leukemic cells to NK cell cytotoxicity and phagocytosis by DC

Quantification of IFN-gamma produced by human purified NK cells following tumor cell stimulation: comparison of three IFN-gamma assays.

Single Domain Antibody-Mediated Blockade of Programmed Death-Ligand 1 on Dendritic Cells Enhances CD8 T-cell Activation and Cytokine Production

The Quest for the Best: How TCR Affinity, Avidity, and Functional Avidity Affect TCR-Engineered T-Cell Antitumor Responses

Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.